Loading live market data…

Relay Therapeutics, Inc.

NASDAQ:RLAY

$19.51 USD

$0.43 (2.25%)

Volume
1.54M
Average Volume
4.15M
Market Capitalization
$3.41B
P/E Ratio
-12.43
Dividend Yield
0.00%
Price Target
$26.00
Year High
$20.79
Year Low
$3.03
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$22.13

RLAY Estimated and Actual Revenue by Quarter

RLAY Estimated and Actual EPS by Quarter

RLAY Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 4 -28.78M -18.45M -25M -28.78M -18.45M -25M
2028-09-30 4 -552.62K -354.24K -480K -552.62K -354.24K -480K
2028-06-30 5 -552.62K -354.24K -480K -552.62K -354.24K -480K
2028-03-31 2 -552.62K -354.24K -480K -552.62K -354.24K -480K
2027-12-31 3 -356.9K -228.78K -310K -356.9K -228.78K -310K
2027-09-30 3 -92103 -59040 -80000 -92103 -59040 -80000
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 4 -62.41M -34.39M -52.16M 312.6M 487.65M 423.57M
2028-09-30 4 -83.94M -46.25M -70.14M 6M 9.36M 8.13M
2028-06-30 5 -83.94M -46.25M -70.14M 6M 9.36M 8.13M
2028-03-31 2 -81.78M -45.07M -68.34M 6M 9.36M 8.13M
2027-12-31 3 -83.79M -46.17M -70.02M 3.88M 6.05M 5.25M
2027-09-30 3 -87.38M -48.15M -73.02M 1M 1.56M 1.36M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 4 18.45M 28.78M 25M 5 -0.34704 -0.19123 -0.29
2028-09-30 4 354.24K 552.62K 480K 5 -0.4667 -0.25717 -0.39
2028-06-30 5 354.24K 552.62K 480K 6 -0.4667 -0.25717 -0.39
2028-03-31 2 354.24K 552.62K 480K 3 -0.45474 -0.25058 -0.38
2027-12-31 3 228.78K 356.9K 310K 2 -0.4659 -0.25673 -0.38933
2027-09-30 3 59040 92103 80000 2 -0.48585 -0.26772 -0.406